Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT04599712 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04599712
- Sponsor
- Janssen Research & Development, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.